FE Combo Test Kit (Fluoroquinolone & Erythromycin)

The rapid test strip detection technology utilizes the principle that the receptor can specifically bind to the ligand, but does not bind to the non-ligand, and the drug residue to be detected is used as a ligand, then the receptor with high specificity is screened out. The binding of the test substance to the receptor surface binding site is examined to detect the drug residue in the sample. Receptor ligand detection technology uses the drug residue to be tested as a ligand, and the specific recognition of drug residues in the sample is skillfully solved by different color changes in different concentrations.

The rapid detection strip based on this principle can identify the parent ring of the drug with high specificity and high affinity. In addition, it has more cross-reaction than the antigen-antibody technology for the same drug, and has high specificity, high sensitivity, strong stability and very strong anti-interference ability.